Introducing QNova LifeSciences
We’re excited to announce that QNova LifeSciences is now doing business as QNova LifeSciences. While our name has changed, our commitment to excellence in FDA regulatory guidance remains the same. This rebrand reflects our mission to accelerate the development of drugs and medical devices for the patients who need them most.
Why Change Names?
Our new name, QNova LifeSciences, better encapsulates what we offer:
Quality, Navigation, Optimization, Validation, and Assurance throughout the regulatory process.
“Our new name reflects the quality and innovation we bring to every partnership, while staying true to our roots of reducing time, risk, and cost for our clients. As QNova LifeSciences, we are proud to continue our mission of guiding drug and medical device companies through the regulatory process with unmatched expertise and precision.”
— Jim Sergi, President of QNova LifeSciences
The Story Behind Our New Name
The name QNova Carries a meaning:
- Q stands for Quality, the cornerstone of our services.
- Nova, meaning “a star that shines brightly,” symbolizes guidance, innovation, and new beginnings. Just as a nova illuminates the night sky, we aim to shine a light on the regulatory process, guiding our clients through every stage of their journey.
Together, QNova reflects innovation, leadership, and a commitment to excellence in FDA regulatory consulting. With QNova LifeSciences, you can trust us to be your guide and partner, helping you achieve success.
What Motivated the Change?
We’ve expanded our offering!
As part of our rebrand, we’re thrilled to announce two new initiatives designed to propel companies toward greater success and accelerated outcomes.
First, QNova Accelerator. Designed to assist companies beyond the regulatory process, this initiative formalizes engagement with our ecosystem to deliver support, resources, and expertise.
Second, QNova Capital. This marks the official launch of our venture arm, providing direct investments and access to our extensive network of bioscience investors, supporting companies from Seed to Series A.
Together, our three new pillars build a comprehensive foundation, ensuring unmatched support and expedited pathways to success. Our name change reflects our growing expertise, the value we provide to our clients, and our expanded offerings through QNova LifeSciences, QNova Accelerator, and QNova Capital.
Regulatory Strategy & Expertise
Unmatched Support Beyond Regulatory
Direct Investment & Access to Capital
QNova Capital
QNova Capital is our venture arm, providing direct investments and access to our extensive network of bioscience investors, supporting companies from Seed to Series A.
About QNova Capital
We are a Strategic Partnership Fund dedicated to de-risking critical aspects of time, resources, and investment for life science innovators. This pillar offers access to QNova Capital SPV Fund for seed to Series A funding, with flexible sizes based on LP interest. Our strategic framework is built on the pillars of commercialization, capital, infrastructure, and resources, ensuring alignment and creating the highest probability of success. Our commitment goes beyond funding: We serve as an extension of management teams for high-growth companies, collectively de-risking the path to commercialization and delivering successful outcomes. Your success is our success.
QNova Capital Portfolio Profiles
- Committed to commercializing life science technologies in the pharma, medical device, diagnostic or digital health space.
- Have a proof of concept or validated the underlying scientific feasibility.
- Secured the licensing of the necessary IP rights to commercialize.
- Preferentially have already completed some basic business programming and customer discovery.
- Have a founder committed to joining the company in an operational capacity in the future.
- Established a legal business entity.
- At least one member of the founding team dedicated to QNova Capital
- Strategic alignment with global healthcare priorities.
- Potential to expand operations and meet market demands.
QNova Accelerator
QNova Accelerator assists companies beyond the regulatory process, this initiative formalizes engagement with our ecosystem to deliver support, resources, and expertise.
Our Accelerator arm provides a customized program that spans the startup journey:
-
- Discovery: Identifying opportunities aligned with market needs, while defining and mitigating the risk potential
- Development: Refining value propositions, investor readiness and accurately project cost and timelines.
- Commercialization: Scaling innovation to meet global standards.
- Access to a broad network of investors and ecosystem
- Curated programing
- Hands-on support
What’s Changing?
Only our name has changed.
Everything else remains the same:
- Our team, ownership, corporate address, and FEIN are unchanged.
- Our services and offerings remain exactly as they were, continuing to deliver the same quality and excellence you’ve come to expect.
- Our logo and brand colors will also stay the same, ensuring familiarity during this transition.
At our core, our mission remains steadfast:
To accelerate the development of drugs and medical devices to market for patients who benefit most.
As we continue to evolve, this name reflects our dedication to helping our clients navigate complex regulatory pathways with precision and expertise, reducing time, risk, and cost.
Frequently Asked Questions (FAQs)
Q: If I’m a client/prospect, what is the legal name of the company and who will my invoices be from?
A: We have changed our legal corporate name to LifeSciences Regulatory Solutions, LLC, but we are doing business as QNova LifeSciences (formerly QNova LifeSciences). Invoices and official documents will bear the new legal name, but our services and operations will remain unchanged. For more questions about how this name change will be applied, please email our finance team here: finance@QNovaLS.com.
Q: Are there changes to your services or team?
A: No, our team, ownership, and services remain the same. The name change simply reflects our ongoing commitment to excellence.
Q: Why did you choose QNova?
A: The name reflects the quality and innovation we provide while symbolizing our role as a guiding star for our clients navigating complex regulatory pathways.
Q: Interested in working with us?
A: If you are interested in partnering with us, please contact info@QNovaLS.com and a member of our team will get right back to you.
Follow for Updates
We’d love to keep you updated on our journey and share insights into our services.
- Follow us on LinkedIn for regular updates.
- Subscribe to our newsletter to stay informed about our events and industry news.
- Contact us to learn more about our rebrand or explore how we can support your projects.
Contact Us
Feel free to contact us with any questions.
Jim Sergi | President & Founder
info@QNovaLS.com
6751 Columbia Gateway Drive, Suite 300, Columbia, MD 21046
www.linkedin.com/in/jim-sergi/
QNova LifeSciences is a global regulatory consulting firm specializing in regulatory and commercialization services for drugs and medical devices. Known for its extensive FDA experience, we guide clients through complex regulatory landscapes with a commitment to reducing time and costs-to-market and enhancing commercial success.
If you are interested in partnering with us, please contact info@QNovaLS.com and a member of our team will get right back to you.